200 related articles for article (PubMed ID: 21231837)
1. Low molecular weight heparin treatment during subsequent pregnancies of women with inherited thrombophilia and previous severe pregnancy complications.
Kupferminc MJ; Rimon E; Many A; Sharon M; Lessing JB; Gamzu R
J Matern Fetal Neonatal Med; 2011 Aug; 24(8):1042-5. PubMed ID: 21231837
[TBL] [Abstract][Full Text] [Related]
2. Low molecular weight heparin versus no treatment in women with previous severe pregnancy complications and placental findings without thrombophilia.
Kupferminc M; Rimon E; Many A; Maslovitz S; Lessing JB; Gamzu R
Blood Coagul Fibrinolysis; 2011 Mar; 22(2):123-6. PubMed ID: 21192252
[TBL] [Abstract][Full Text] [Related]
3. Treatment of adverse perinatal outcome in inherited thrombophilias: a clinical study.
Kosar A; Kasapoglu B; Kalyoncu S; Turan H; Balcik OS; Gümüs EI
Blood Coagul Fibrinolysis; 2011 Jan; 22(1):14-8. PubMed ID: 21042205
[TBL] [Abstract][Full Text] [Related]
4. [Thrombophilia, preeclampsia and other pregnancy complications].
Vucić N; Frleta M; Petrović D; Ostojić V
Acta Med Croatica; 2009 Oct; 63(4):297-305. PubMed ID: 20034330
[TBL] [Abstract][Full Text] [Related]
5. Modulation of systemic hemostatic parameters by enoxaparin during gestation in women with thrombophilia and pregnancy loss.
Sarig G; Blumenfeld Z; Leiba R; Lanir N; Brenner B
Thromb Haemost; 2005 Nov; 94(5):980-5. PubMed ID: 16363240
[TBL] [Abstract][Full Text] [Related]
6. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.
Brenner B; Hoffman R; Blumenfeld Z; Weiner Z; Younis JS
Thromb Haemost; 2000 May; 83(5):693-7. PubMed ID: 10823264
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Inherited Thrombophilia Types and Low Molecular Weight Heparin Treatment on Pregnancy Complications in Women with Previous Adverse Outcome.
Aracic N; Roje D; Jakus IA; Bakotin M; Stefanovic V
Yonsei Med J; 2016 Sep; 57(5):1230-5. PubMed ID: 27401656
[TBL] [Abstract][Full Text] [Related]
8. Inherited thrombophilia: treatment during pregnancy.
De Carolis S; Ferrazzani S; De Stefano V; Garofalo S; Fatigante G; Rossi E; Leone G; Caruso A
Fetal Diagn Ther; 2006; 21(3):281-6. PubMed ID: 16601339
[TBL] [Abstract][Full Text] [Related]
9. Prophylaxis and treatment of thrombophilia in pregnancy.
Gris JC; Lissalde-Lavigne G; Quéré I; Dauzat M; Marès P
Curr Opin Hematol; 2006 Sep; 13(5):376-81. PubMed ID: 16888444
[TBL] [Abstract][Full Text] [Related]
10. Low-molecular-weight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomized placebo-controlled trial.
Qublan H; Amarin Z; Dabbas M; Farraj AE; Beni-Merei Z; Al-Akash H; Bdoor AN; Nawasreh M; Malkawi S; Diab F; Al-Ahmad N; Balawneh M; Abu-Salim A
Hum Fertil (Camb); 2008 Dec; 11(4):246-53. PubMed ID: 19085261
[TBL] [Abstract][Full Text] [Related]
11. Low molecular weight heparin treatment and impact of inherited thrombophilia type in pregnancies with previous adverse outcome.
Aracic N; Roje D; Drmic Hofman I; Capkun V; Stefanovic V
J Matern Fetal Neonatal Med; 2015 Feb; 28(3):306-10. PubMed ID: 24749801
[TBL] [Abstract][Full Text] [Related]
12. Thromboprophylaxis and pregnancy outcomes in asymptomatic women with inherited thrombophilias.
Warren JE; Simonsen SE; Branch DW; Porter TF; Silver RM
Am J Obstet Gynecol; 2009 Mar; 200(3):281.e1-5. PubMed ID: 19114274
[TBL] [Abstract][Full Text] [Related]
13. Recurrence and severity of abnormal pregnancy outcome in patients treated by low-molecular-weight heparin: a prospective pilot study.
Conserva V; Muggiasca M; Arrigoni L; Mantegazza V; Rossi E; Ferrazzi E
J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1467-73. PubMed ID: 22122225
[TBL] [Abstract][Full Text] [Related]
14. Antithrombotic prophylaxis during pregnancy in women with deficiency of natural anticoagulants.
Grandone E; De Stefano V; Rossi E; Cappucci F; Colaizzo D; Margaglione M
Blood Coagul Fibrinolysis; 2008 Apr; 19(3):226-30. PubMed ID: 18388503
[TBL] [Abstract][Full Text] [Related]
15. [Impact of inherited thrombophilia on the development of some pregnancy complications].
Koleva R; Dimitrova V; Chernev T; Savov A; Karag'ozova Zh; Mazneŭkova V; Kremenski I
Akush Ginekol (Sofiia); 2005; 44(5):18-26. PubMed ID: 16313049
[TBL] [Abstract][Full Text] [Related]
16. Recurrence rate of pre-eclampsia in women with thrombophilia influenced by low-molecular-weight heparin treatment?
Kalk JJ; Huisjes AJ; de Groot CJ; van Beek E; van Pampus MG; Spaanderman ME; van Eyck J; Oei SG; Bezemer PD; de Vries JI
Neth J Med; 2004 Mar; 62(3):83-7. PubMed ID: 15209472
[TBL] [Abstract][Full Text] [Related]
17. Safety of low-molecular-weight heparin during pregnancy: a retrospective controlled cohort study.
Galambosi PJ; Kaaja RJ; Stefanovic V; Ulander VM
Eur J Obstet Gynecol Reprod Biol; 2012 Aug; 163(2):154-9. PubMed ID: 22658765
[TBL] [Abstract][Full Text] [Related]
18. Successful pregnancy outcome in women with bad obstetric history and recurrent fetal loss due to thrombophilia: effect of unfractionated heparin and low-molecular weight heparin.
Ghosh K; Shetty S; Vora S; Salvi V
Clin Appl Thromb Hemost; 2008 Apr; 14(2):174-9. PubMed ID: 18160603
[TBL] [Abstract][Full Text] [Related]
19. Effects of anticoagulant therapy on pregnancy outcomes in patients with thrombophilia and previous poor obstetric history.
Mutlu I; Mutlu MF; Biri A; Bulut B; Erdem M; Erdem A
Blood Coagul Fibrinolysis; 2015 Apr; 26(3):267-73. PubMed ID: 25268607
[TBL] [Abstract][Full Text] [Related]
20. Outcome of pregnancies in women with thrombophilic disorders.
Sucak A; Acar K; Celen S; Danisman N; Sucak GT
J Obstet Gynaecol; 2010; 30(8):847-51. PubMed ID: 21126128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
